Stay updated on Autologous LN-145 in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Autologous LN-145 in NSCLC Clinical Trial page.

Latest updates to the Autologous LN-145 in NSCLC Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check35 days agoNo Change Detected
- Check42 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
- Check49 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.1%
- Check63 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.1%
- Check70 days agoChange DetectedThe type of intervention has been updated from version v2.13.3 to v2.14.0.SummaryDifference0.2%
- Check99 days agoChange DetectedThe study has expanded to include 49 locations, with new recruiting sites added in Australia, Germany, Switzerland, and the United Kingdom, while the previous count of 44 locations has been removed.SummaryDifference3%
Stay in the know with updates to Autologous LN-145 in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Autologous LN-145 in NSCLC Clinical Trial page.